{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:18:41Z","timestamp":1791044321970,"version":"4.1.0"},"reference-count":24,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"abstract":"<jats:title>3-D Structure of Serum Paraoxonase 1 Sheds Light on Its Activity, Stability, Solubility and Crystallizability<\/jats:title><jats:p>Serum paraoxonases (PONs) exhibit a wide range of physiologically important hydrolytic activities, including drug metabolism and detoxification of nerve gases. PON1 and PON3 reside on high-density lipoprotein (HDL) (the \"good cholesterol\"), and are involved in the alleviation of atherosclerosis. Members of the PON family have been identified not only in mammals and other vertebrates, but also in invertebrates. We earlier described the first crystal structure of a PON family member, a directly-evolved variant of PON1, at 2.2 \u00c5 resolution. PON1 is a 6-bladed beta-propeller with a unique active-site lid which is also involved in binding to HDL. The 3-D structure, taken together with directed evolution studies, permitted analysis of mutations which enhanced the stability, solubility and crystallizability of this PON1 variant. The structure permits a detailed description of PON1's active site and suggests possible mechanisms for its catalytic activity on certain substrates.<\/jats:p>","DOI":"10.2478\/v10004-007-0028-0","type":"journal-article","created":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T14:35:28Z","timestamp":1192631728000},"page":"347-353","source":"Crossref","is-referenced-by-count":27,"title":["3-D Structure of Serum Paraoxonase 1 Sheds Light on Its Activity, Stability, Solubility and Crystallizability"],"prefix":"10.2478","volume":"58","author":[{"given":"Michal","family":"Harel","sequence":"first","affiliation":[{"name":"Weizmann Institute of Science, Rehovot, Israel1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Brumshtein","sequence":"additional","affiliation":[{"name":"Weizmann Institute of Science, Rehovot, Israel1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Meged","sequence":"additional","affiliation":[{"name":"Weizmann Institute of Science, Rehovot, Israel1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hay","family":"Dvir","sequence":"additional","affiliation":[{"name":"Weizmann Institute of Science, Rehovot, Israel1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimond","family":"Ravelli","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, Grenoble Outstation, Grenoble, France2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McCarthy","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, Grenoble Outstation, Grenoble, France2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"Toker","sequence":"additional","affiliation":[{"name":"Weizmann Institute of Science, Rehovot, Israel1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Silman","sequence":"additional","affiliation":[{"name":"Weizmann Institute of Science, Rehovot, Israel1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Sussman","sequence":"additional","affiliation":[{"name":"Weizmann Institute of Science, Rehovot, Israel1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00210-003-0833-1","article-title":"Pharmacogenetics of paraoxonases: a brief review","volume":"369","author":"D Draganov","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"A Lusis","year":"2000","journal-title":"Nature"},{"key":"3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"D Shih","year":"1998","journal-title":"Nature"},{"key":"4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"M Mackness","year":"1991","journal-title":"Fed Eur Biochem Soc Lett"},{"key":"5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.ATV.21.4.542","article-title":"Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids","volume":"21","author":"S Reddy","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3540001","article-title":"Hydrolysis of platelet-activating factor by human serum paraoxonase","volume":"354","author":"L Rodrigo","year":"2001","journal-title":"Biochem J"},{"key":"7","doi-asserted-by":"crossref","first-page":"24473","DOI":"10.1074\/jbc.M010459200","article-title":"Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor","volume":"276","author":"Z Ahmed","year":"2001","journal-title":"J Biol Chem"},{"key":"8","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1074\/jbc.275.6.3957","article-title":"Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation","volume":"275","author":"H Jakubowski","year":"2000","journal-title":"J Biol Chem"},{"key":"9","article-title":"High density lipoprotein structure","volume":"8","author":"S Lund-Katz","year":"2003","journal-title":"Front Biosci"},{"key":"10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0021-9150(01)00646-3","article-title":"Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase","volume":"161","author":"B Fuhrman","year":"2002","journal-title":"Atherosclerosis"},{"key":"11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.ATV.0000060462.35946.B3","article-title":"Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation","volume":"23","author":"O Rozenberg","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"12","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/01.ATV.19.9.2214","article-title":"Human serum Paraoxonase\/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity","volume":"19","author":"R Sorenson","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1073\/pnas.2536901100","article-title":"Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization","volume":"101","author":"A Aharoni","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nsmb767","article-title":"Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes","volume":"11","author":"M Harel","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0003-4509(07)90023-1","article-title":"Discovery and crystallographic structure of human apolipoprotein","volume":"65","author":"R Morales","year":"2000","journal-title":"Ann Pharm"},{"key":"16","doi-asserted-by":"crossref","first-page":"33386","DOI":"10.1074\/jbc.M200108200","article-title":"Oligomeric states of the detergent-solubilized human serum paraoxonase (PON1)","volume":"277","author":"D Josse","year":"2002","journal-title":"J Biol Chem"},{"key":"17","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1074\/jbc.M512595200","article-title":"The catalytic His dyad of High Density Lipoprotein-associated serum paraoxonase-I (PON1) is essential for PON1-mediated inhibition of Low Density Lipoprotein oxidation and stimulation of macrophage cholesterol efflux","volume":"281","author":"M Rosenblat","year":"2006","journal-title":"J Biol Chem"},{"key":"18","doi-asserted-by":"crossref","first-page":"7649","DOI":"10.1074\/jbc.M512594200","article-title":"The histidine-115 histidine-134 dyad mediates the lactonase activity of mammalian serum paraoxonases","volume":"281","author":"O Khersonsky","year":"2006","journal-title":"J Biol Chem"},{"key":"19","first-page":"935","article-title":"Comparison of purified human and rabbit serum paraoxonases","volume":"23","author":"C Kuo","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.sbi.2005.01.001","article-title":"Directed evolution of proteins for heterologous expression and stability","volume":"15","author":"C Roodveldt","year":"2005","journal-title":"Curr Opin Struct Biol"},{"key":"21","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1021\/bi961576x","article-title":"Phospholipase A2 engineering. Structural and functional roles of the highly conserved active site residue aspartate-99","volume":"36","author":"K Sekar","year":"1997","journal-title":"Biochemistry"},{"key":"22","first-page":"493","article-title":"Crystal structure of diisopropylfluorophosphatase from","volume":"9","author":"E Scharff","year":"2001","journal-title":"Loligo vulgaris"},{"key":"23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1367-5931(02)00017-0","article-title":"Genetic screens and directed evolution for protein solubility","volume":"7","author":"G Waldo","year":"2003","journal-title":"Curr Opin Chem Biol"},{"key":"24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/protein\/gzi005","article-title":"Directed evolution of phosphotriesterase from Pseudomonas diminuta for heterologous expression in Escherichia coli results in stabilization of the metal-free state","volume":"18","author":"C Roodveldt","year":"2005","journal-title":"Protein Eng Des Sel"}],"container-title":["Archives of Industrial Hygiene and Toxicology"],"original-title":[],"link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/aiht\/58\/3\/article-p347.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/content.sciendo.com\/downloadpdf\/journals\/aiht\/58\/3\/article-p347.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T18:24:08Z","timestamp":1590863048000},"score":1,"resource":{"primary":{"URL":"https:\/\/content.sciendo.com\/doi\/10.2478\/v10004-007-0028-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":24,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.2478\/v10004-007-0028-0","relation":{},"ISSN":["0004-1254"],"issn-type":[{"value":"0004-1254","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}